Bots, editor, reviewer, Administrators
13,951
edits
Feed:Trial Acronyms: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 111: | Line 111: | ||
"HACA" : "Hypothermia After Cardiac Arrest", | "HACA" : "Hypothermia After Cardiac Arrest", | ||
"CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance", | "CHARISMA" : "Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance", | ||
"DAPA-HF" : "Dapagliflozin in Heart Failure", | |||
"RAVE" : "Rituximab in ANCA-Associated Vasculitis", | "RAVE" : "Rituximab in ANCA-Associated Vasculitis", | ||
"ARREST" : "Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia", | "ARREST" : "Adjunctive rifampicin for Staphylococcus Aureus Bacteraemia", | ||
| Line 242: | Line 243: | ||
"CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition", | "CHAMPION PHOENIX" : "Cangrelor versus standard therapy to achieve optimal management of platelet inhibition", | ||
"NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design", | "NA-ACCORD" : "North American AIDS Cohort Collaboration on Research and Design", | ||
"RE-ALIGN" : "Randomized, Phase II Study to Evaluate the Safety and Pharmacokinetics of Oral Dabigatran Etexilate in Patients after Heart Valve Replacement", | |||
"ASPREE" : "Aspirin in Reducing Events in the Elderly", | "ASPREE" : "Aspirin in Reducing Events in the Elderly", | ||
"CANVAS" : "Canagliflozin Cardiovascular Assessment Study", | "CANVAS" : "Canagliflozin Cardiovascular Assessment Study", | ||
"SEPSISPAM" : "Sepsis and Mean Arterial Pressure", | "SEPSISPAM" : "Sepsis and Mean Arterial Pressure", | ||